| 3481 |
7CU5 |
A_Q |
camrelizumab scFv |
Programmed cell death protein 1(PD-1) |
Homo sapiens |
XRD |
2.81 | 10.15252/embr.202051444 |
| 3482 |
7CU5 |
B_E |
camrelizumab scFv |
Programmed cell death protein 1(PD-1) |
Homo sapiens |
XRD |
2.81 | 10.15252/embr.202051444 |
| 3483 |
7CVS |
CD_A |
7CVS Fab |
H(+)/Cl(-) exchange transporter ClcA |
Escherichia coli MS 198-1, Mus musculus |
XRD |
3.01 | 10.1016/j.jmb.2021.166886 |
| 3484 |
7CVS |
EF_B |
7CVS Fab |
H(+)/Cl(-) exchange transporter ClcA |
Escherichia coli MS 198-1, Mus musculus |
XRD |
3.01 | 10.1016/j.jmb.2021.166886 |
| 3485 |
7CVT |
CD_A |
7CVT Fab |
H(+)/Cl(-) exchange transporter ClcA |
Escherichia coli MS 198-1, Mus musculus |
XRD |
2.9 | 10.1016/j.jmb.2021.166886 |
| 3486 |
7CVT |
EF_B |
7CVT Fab |
H(+)/Cl(-) exchange transporter ClcA |
Escherichia coli MS 198-1, Mus musculus |
XRD |
2.9 | 10.1016/j.jmb.2021.166886 |
| 3487 |
7CWL |
HL_A |
P17 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.8 | 10.1038/s41422-020-00444-y |
| 3488 |
7CWL |
GJ_B |
P17 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.8 | 10.1038/s41422-020-00444-y |
| 3489 |
7CWL |
IK_C |
P17 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.8 | 10.1038/s41422-020-00444-y |
| 3490 |
7CWM |
HL_A |
P17 Fv |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.6 | 10.1038/s41422-020-00444-y |
| 3491 |
7CWM |
GJ_B |
P17 Fv |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.6 | 10.1038/s41422-020-00444-y |
| 3492 |
7CWM |
IK_C |
P17 Fv |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.6 | 10.1038/s41422-020-00444-y |
| 3493 |
7CWN |
GF_A |
P17 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1038/s41422-020-00444-y |
| 3494 |
7CWN |
KI_B |
P17 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1038/s41422-020-00444-y |
| 3495 |
7CWN |
LJ_C |
P17 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1038/s41422-020-00444-y |
| 3496 |
7CWN |
OM_A |
H014 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1038/s41422-020-00444-y |
| 3497 |
7CWN |
ED_B |
H014 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1038/s41422-020-00444-y |
| 3498 |
7CWN |
HN_C |
H014 Fab |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.2 | 10.1038/s41422-020-00444-y |
| 3499 |
7CWO |
HL_A |
P17 Fv |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.9 | 10.1038/s41422-020-00444-y |
| 3500 |
7CWS |
LC_Q |
FC05 Fv |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.4 | 10.1038/s41422-020-00446-w |